hrcak mascot   Srce   HID

Review article

ROLE OF NEOADJUVANT CHEMOTHERAPY IN THE ADVANCED OVARIAN CANCER

Višnja Mataga
Višnja Matković

Fulltext: croatian, pdf (201 KB) pages 0-0 downloads: 77* cite
APA 6th Edition
Mataga, V. & Matković, V. (2013). ULOGA NEOADJUVANTNE KEMOTERAPIJE KOD UZNAPREDOVALOG RAKA JAJNIKA. Liječnički vjesnik, 135 (1-2), 0-0. Retrieved from https://hrcak.srce.hr/172462
MLA 8th Edition
Mataga, Višnja and Višnja Matković. "ULOGA NEOADJUVANTNE KEMOTERAPIJE KOD UZNAPREDOVALOG RAKA JAJNIKA." Liječnički vjesnik, vol. 135, no. 1-2, 2013, pp. 0-0. https://hrcak.srce.hr/172462. Accessed 22 Feb. 2020.
Chicago 17th Edition
Mataga, Višnja and Višnja Matković. "ULOGA NEOADJUVANTNE KEMOTERAPIJE KOD UZNAPREDOVALOG RAKA JAJNIKA." Liječnički vjesnik 135, no. 1-2 (2013): 0-0. https://hrcak.srce.hr/172462
Harvard
Mataga, V., and Matković, V. (2013). 'ULOGA NEOADJUVANTNE KEMOTERAPIJE KOD UZNAPREDOVALOG RAKA JAJNIKA', Liječnički vjesnik, 135(1-2), pp. 0-0. Available at: https://hrcak.srce.hr/172462 (Accessed 22 February 2020)
Vancouver
Mataga V, Matković V. ULOGA NEOADJUVANTNE KEMOTERAPIJE KOD UZNAPREDOVALOG RAKA JAJNIKA. Liječnički vjesnik [Internet]. 2013 [cited 2020 February 22];135(1-2):0-0. Available from: https://hrcak.srce.hr/172462
IEEE
V. Mataga and V. Matković, "ULOGA NEOADJUVANTNE KEMOTERAPIJE KOD UZNAPREDOVALOG RAKA JAJNIKA", Liječnički vjesnik, vol.135, no. 1-2, pp. 0-0, 2013. [Online]. Available: https://hrcak.srce.hr/172462. [Accessed: 22 February 2020]

Abstracts
Primary surgery is still thought as cornerstone in treating locally advanced epithelial ovarian cancer. Subsequent to surgery is usually chemotherapy. Survival of patients with advanced epithelial ovarian cancer, according to International Federation of Gynecology and Obstetrics (FIGO) stage IIIC and IV, who make over 75% of total patients with ovarian cancer is still unsatisfactory. With these patients it is often impossible to perform adequate resection of all changes in the abdomen (optimal debulking) and so is the effectiveness of chemotherapy decreased. Therefore as a possible optimal approach appears neoadjuvant chemotherapy (NAC) that leads to the decreasing of the primary tumour and possible metastasis in the abdomen. With such an approach an operation procedure is shorter and easier after 3–4 cycles of chemotherapy with a stronger possibility of optimal »debulking«.

Keywords
Ovarian neoplasms – pathology, drug therapy, surgery; Neoplasms, glandular and epithelial – pathology, drug therapy, surgery; Antineoplastic agents – therapeutic use; Neoadjuvant therapy; Neoplasm staging; Gynecologic surgical procedures

Hrčak ID: 172462

URI
https://hrcak.srce.hr/172462

[croatian]

Visits: 197 *